Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer

Clinical trial NCT00040170 · TERMINATED

Trial details

NCT number: NCT00040170
Sponsor: Transgene
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2002-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.